RELATING TO TRAFFIC CITATIONS.
House Bill 334 ensures high-risk men can access annual prostate cancer screenings without cost-sharing, removing financial barriers for early detection and treatment.
House Bill 334 ensures high-risk men can access annual prostate cancer screenings without cost-sharing, removing financial barriers for early detection and treatment.
Bill Number: HB 334
Title: Health care policies; eliminate cost-sharing for prostate screening coverage of high-risk men
Status: Currently Indefinitely Postponed
Introduced: February 25, 2025
Classification: Bill
Subject: Insurance
House Bill 334 aims to enhance access to prostate cancer screening for high-risk men by eliminating cost-sharing requirements. The bill recognizes the increased risk of prostate cancer among certain demographics and seeks to ensure that these individuals can receive necessary screenings without financial barriers.
Coverage Requirements:
Cost-Sharing Elimination:
Amendments:
The implementation of HB 334 is projected to increase costs for state health insurance plans:
- State Employees' Health Insurance Plan (SEHIP): Estimated increase of $200,000 annually.
- Public Education Employees Health Insurance Plan (PEEHIP): Estimated increase of $160,000 annually.
House Bill 334 represents a significant step towards improving health outcomes for high-risk men by ensuring they have access to prostate cancer screenings without financial impediments. While the bill has been postponed, its provisions highlight the ongoing discussions around health equity and preventive care in the legislative arena.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.